Skip Navigation


European Heart Journal Advance Access originally published online on March 31, 2005
European Heart Journal 2005 26(12):1147-1149; doi:10.1093/eurheartj/ehi247
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/12/1147    most recent
ehi247v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mukherjee, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukherjee, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Optimizing management of patients with coronary artery disease: how do we get there?

Debabrata Mukherjee1,*

Gill Heart Institute, Division of Cardiovascular Medicine, University of Kentucky, 900 S. Limestone Street, 326 Wethington Building, Lexington, KY 40536-0200, USA

* Corresponding author. Tel: +1 859 323 5630; fax: +1 859 323 6475. E-mail address: mukherjee@uky.edu

This editorial refers to ‘Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization’{dagger} by M.J. Lenzen et al., on page 1169

The first 10% of the full text of this article appears below.

Cardiovascular disease remains the leading cause of morbidity and mortality globally.1 Despite marked advances in the fields of mechanical and pharmacological therapies for coronary artery disease there continues to remain large gaps in the utilization of these effective therapies. Over the last decade, several pharmacological therapies have been shown to be very effective in reducing morbidity and mortality in patients with cardiovascular diseases. These agents, including antiplatelet agents, statins, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers, although individually very effective in reducing secondary cardiovascular events are even more effective when used in combination . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization
M.J. Lenzen, E. Boersma, M.E. Bertrand, W. Maier, C. Moris, F. Piscione, U. Sechtem, E. Stahle, P. Widimsky, P. de Jaegere, W.J.M. Scholte op Reimer, N. Mercado, and W. Wijns
EHJ 2005 26: 1169-1179. [Abstract] [FREE Full Text]